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ABSTRACT
Recent evidence from our laboratory has demonstrated that high salt (Δ0.05 
M NaCl) induced inflammatory response and cancer cell proliferation through 
salt inducible kinase-3 (SIK3) upregulation. As calcium influx is known to effect 
inflammatory response and drug resistance, we examined the impact of high salt on 
calcium influx in breast cancer cells. Treatment of MCF-7 and MDA-MB-231 cells with 
high salt induced an enhanced intracellular calcium intensity, which was significantly 
decreased by store operated calcium entry (SOCE) inhibitor co-treatment. Further, 
high salt induced P-glycoprotein (P-gp) mediated paclitaxel drug resistance in breast 
cancer cells. Murine tumor studies demonstrated that injection of MCF-7 cells cultured 
in high salt, exerted higher tumorigenicity compared to the basal cultured counterpart. 
Knock down of SIK3 by specific shRNA inhibited tumorigenicty, expression of SOCE 
regulators and P-gp activity, suggesting SIK3 is an upstream mediator of SOCE induced 
calcium influx. Furthermore, small molecule inhibitor, prostratin, exerted anti-tumor 
effect in murine models through SIK3 inhibition. Taken together, we conclude that 
SIK3 is an upstream regulator of store operated calcium entry proteins, Orai1 and 
STIM1, and mediates high salt induced inflammatory cytokine responses and P-gp 
mediated drug resistance. Therefore, small molecule inhibitors, such as prostratin, 
could offer novel anti-cancer approaches. 
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INTRODUCTION
Breast cancer is the second leading cause of cancer 
related mortality in American women [1]. Despite the 
significant improvement in both diagnostic and therapeutic 
modalities for the treatment of cancer patients, about 
30% of patients with early-stage breast cancer succumb 
to recurrent disease [2]. While, systemic anti-cancer 
agents are effective at the beginning of therapy both in 
primary breast cancers and metastases, however, after a 
variable period of time, resistance to therapy is common 
mainly due to emergence of tumor variance phenotypes 
[3]. Although the elimination of transformed cells by 
host immune responses result in immune sculpting, and 
emergence of new treatment resistant tumor variants, the 
exact mechanisms and molecular factors in the tumor 
microenvironment mediating this cancer resistance are 
yet undefined [4].
Recent evidence from our laboratory has 
demonstrated that under high salt (50 mM above basal 
              Research Paper
Oncotarget25194www.oncotarget.com
condition Δ0.05 M NaCl) external treatment conditions, 
breast cancer cells induce chronic inflammatory response 
with enhanced expression of inflammatory cytokines 
and reactive oxygen/nitrogen species (RNS/ROS) [5, 
6]. Interestingly, sodium-magnetic resonance imaging 
(Na23-MRI) studies performed in breast cancer patients 
have demonstrated an increased sodium content of up to 
50–70% in breast tumors as compared with surrounding 
soft tissue [7, 8]. These Na23-MRI studies in corroboration 
with our in vitro data argue for a potential effector role 
of salt in the tumor microenvironment towards promotion 
of tumor progression and probably treatment resistance in 
breast cancer cells. 
Calcium influx mediated signaling response 
is well known to induce expression and secretion of 
inflammatory cytokines [9]. Altered expression of STIM1 
and Orai1, key molecular components of store operated 
calcium entry (SOCE) pathways have been reported in 
cervical cancer [10], breast cancer [11], and esophageal 
cancer [12]. Further, P-glycoprotein upregulation is 
well known to induce treatment resistance in cancer 
cells. P-glycoprotein is a product of the multi drug 
resistance gene complex (MDR) and functions as an 
energy-dependent drug efflux pump and acts by active 
intra-cellular removal of anti-cancer drugs and there by 
development of treatment-resistant tumor variants [13]. In 
our current communication, we studied the potential role 
of high salt treatment towards induction of calcium influx 
mediated inflammatory signaling and its interplay towards 
induction of P-glycoprotein mediated treatment resistance.
RESULTS
Store operated calcium channels are critical 
for high salt mediated inflammatory cytokine 
release
We have previously demonstrated that high 
salt treatment (Δ0.05 M NaCl) induced expression of 
inflammatory cytokines by breast cancer cells [5]. As the 
ubiquitous second messenger, Ca2+, is one of the critical 
regulators of inflammatory responses, we investigated the 
interplay of Ca2+ influx on high salt mediated cytokine 
release [14]. Towards this we first performed a Fluo-3 
(a fluorescent Ca2+ indicator)-based Ca2+ measurement, 
to determine the induction of calcium influx following 
high salt treatment on breast cancer cell lines, MCF-7 and 
MDA-MB-231. As shown in Figure 1, high salt treatment 
induced an enhanced calcium influx peak. Normally, the 
cytoplasmic calcium influx peak consists of two phases, a 
peak phase contributed by Ca2+ release from intracellular 
Ca2+ stores and a plateau phase contributed by Ca2+ influx. 
As shown in Figure 1A, SKF96365, an inhibitor of store 
operated Ca2+ entry (SOCE) [15], decreased the amplitude 
of the plateau phase of the high salt-induced Ca2+ response 
without affecting the peak phase. Similar results were 
observed with EGTA, which chelates extracellular Ca2+. 
Quantitative analysis of the fluorescence intensity changes 
of the plateau phase demonstrated that high salt induced a 
76 ± 10% calcium influx induced Fluo-3 intensity change. 
Here, 0.1 M mannitol is used as a negative control for the 
high salt (0.05 M NaCl) treatment. NaCl being a bi-ionic 
species the ionic osmolar equivalent of 0.05 M NaCl is 
0.1 M mannitol. As shown in Figure 1A, treatment of 
cancer cells with equivalent mannitol concentration did 
not induce a calcium response, and thus suggesting that 
the calcium signal changes were a direct consequence of 
salt induced phenomenon and not a secondary effect as 
consequence of osmolar-changes induced by high salt. 
Interestingly, SKF96365 decreased the change (24 ± 6%, 
p < 0.05) in plateau phase of calcium influx, similar to the 
effect shown by EGTA. However, inhibitors of voltage-
gated Ca2+ channels (nimodipine), NMDA receptors (2-
AP), or AMPA receptors (CNQX) had minimal effect 
(Figure 1A and 1B). Further, ELISA based analysis of the 
TNF-α (Figure 1C) in the cell supernatant from MCF-7 
cells following high salt treatment was determined to be 
583 ± 109 pg/mL (p < 0.05, compared to basal normal 
salt treatment which is 161 ± 109 pg/mL). However, with 
SKF96365, a SOCE specific inhibitor treatment under high 
salt conditions induced inhibition of TNF-α secretion (243 
± 64 pg/mL, P < 0.05 compared to high salt treatment). 
Similarly, ELISA based analysis of the CXCL12 (Figure 
1D) in the cell supernatant from MCF-7 cells following 
high salt treatment was determined to be 314 ± 54 pg/mL 
(p < 0.05, compared to basal normal salt treatment which 
is 73 ± 32 pg/mL). However, with SKF96365, a SOCE 
specific inhibitor treatment under high salt conditions 
induced inhibition of CXCL12 secretion (138 ± 44 pg/mL, 
P < 0.05 compared to high salt treatment). Collectively, 
the inhibition of SOCE demonstrated decreased expression 
of high salt-induced release of inflammatory cytokine and 
chemokine, TNF-α and CXCL12, respectively, in the 
breast cancer cells MCF-7 and MDA-MB-231 (Figure 1C, 
1D). Therefore, these data suggest that high salt induces 
its inflammatory response through upregulation of SOCE 
mediated Ca2+ influx.
STIM1 and Orai1 are required for high salt 
mediated inflammatory response
Several studies from other laboratories have 
demonstrated that the proteins, STIM1 and Orai1, are 
responsible for store-operated Ca2+ entry [16]. To examine 
whether STIM1 and Orai1 are important molecular 
components involved in high salt mediated inflammatory 
responses, we used RNA interference (RNAi) to knock 
down STIM1 and Orai1 in MCF-7 and MDA-MB-231 
human breast cancer cells. The successful knockdown 
of STIM1 or Orai1 mRNA was confirmed by western 
blot (Figure 2A–2C). Furthermore, the reduction of 
functional store-operated Ca2+ entry was verified by Fluo-
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3-based measurements (Figure 2D). Store-operated Ca2+ 
channels are activated when internal Ca2+ stores are empty. 
Thapsigargin was used to empty the intracellular Ca2+ 
stores in the absence of extracellular Ca2+. The Ca2+ influx 
was then measured by addition of 2 mM extracellular 
Ca2+. Both STIM1 and Orai1 siRNAs reduced the level 
of Ca2+ influx compared to control scramble siRNA 
(Figure 2D). Further, importantly, knock down of STIM1 
and Orai1 inhibited the high salt mediated inflammatory 
response (Figure 2E and 2F) by MCF-7 and MDA-
MB-231.Therefore, these data demonstrate that SOCE 
mediated Ca2+ influx is critical for the high salt induces its 
inflammatory response in breast cancer cells.
High salt induces upregulation of P-glycoprotein, 
a drug resistance efflux pump
Our previous studies have demonstrated that high 
salt treatment (Δ0.05 M NaCl) along with inflammatory 
stress (as noted by enhanced reactive nitrogen and 
oxygen species) has also induced a 24% proliferation 
of cancer cells compared to basal culture conditions [5]. 
As chronic inflammatory stress is known to result in 
cancer cell variants, we next performed experiments to 
determine if high salt also induces treatment resistance 
phenotype in breast cancer cells [17]. Towards this, 
we have passaged MCF-7 and MDA-MB-231 cells 
in high salt for eight passages and will be referred 
to as MCF-7s and 231s, respectively. As shown in 
Figure 3A and 3B, high salt treated MCF-7s were 
resistant to paclitaxel induced cytotoxicity as measured 
by IC50 and Cmax compared to basal culture conditions. 
Further literature evidence suggests that the emergence 
of chemotherapeutic multidrug resistance (MDR) was 
associated with increased levels of a transmembrane 
glycoprotein, P-glycoprotein (P-gp). Therefore, we tested 
if there is change in P-gp expression following high salt 
treatment. As shown in Figure 3C, high salt treatment 
in both MCF-7s and 231s cell lines, induced enhanced 
expression of chemoresistance factor, P-gp. Further, it is 
important to note that knock down of SOCE Ca2+ regulator 
molecules STIM1 and Orai1-enhanced paclitaxel 
sensitivity (Figure 3B) and reduced the expression of 
expression of P-gp (Figure 3C). This suggests that high 
salt mediated calcium influx regulates the development 
of drug resistance in salt passaged breast cancer cells. 
Further, to determine the functionality of the high salt 
mediated expression of P-gp, a membrane drug efflux 
channel, we performed rhodamine 123 efflux assay. The 
cells are pre-treated with rhodamine 123 for 1 hour, and 
then washed and measured for intracellular accumulation 
of the dye. The P-gp is a specific membrane protein 
which facilitates the efflux of rhodamine123, and cells 
with higher expression of P-gp have poor intracellular 
accumulation of rhodamine 123. As shown in Figure 3D, 
high salt passaged cells (MCF-7s and 231s) demonstrated 
decreased cellular accumulation of rhodamine 123 (37 ± 
8 RFU and 22 ± 7 RFU, respectively) compared to breast 
Figure 1: (A) Fluo-3 Ca2+ measurement indicates that SKF96365 (10 µM, inhibitor of store operated Ca2+ entry) and EGTA (2 mM) 
treatments decrease high salt (Δ0.05 M NaCl) induced Ca2+ influx in MCF-7 breast cancer cells. The basal (normal salt) treatment is 
indicated in red as control. While inhibitors of voltage-gated Ca2+ channels (nimodipine, 10 µM), NMDA receptors (2-AP, 10 µM), 
or AMPA receptors (CNQX, 10 µM) had no effect on high salt-induced calcium influx. (B) Quantitative changes high salt induced 
calcium influx measured by relative florescence shift (ΔF/F*100) in MCF-7 and MDA-MB-231 breast cancer cells following various 
treatment conditions. F1, plateau phase fluorescence; F0, baseline fluorescence. (C, D) Inhibition of inflammatory cytokine TNF-α (C), 
and inflammatory chemokine CXCL12 (D) expression MCF-7 and MDA-MB-231 breast cancer cells in following treatment with SOCE 
inhibitor. Data were representative of five experiments and shown as mean ± SEM, p < 0.05.
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cancer cells cultured under basal condition (rhodamine 
efflux in MCF-7 and MDA-231 is normalized 100 RFU). 
In the presence of cyclospoin-A, a known specific P-gp 
inhibitor [18], and P-gp knock down there is enhanced 
intracellular rhodamine 123 accumulation in the high 
salt passaged cancer cells, thus clearly suggesting that 
the drug efflux functionality of P-gp is specifically 
upregulated in the high salt mediated drug resistance. 
Importantly, knock down of SOCE calcium regulators 
STIM1 and Orai1 (Figure 3D) increased intracellular 
rhodamine 123 accumulation and thus arguing for a 
critical role of SOCE mechanism in high salt mediated 
P-gp expression leading to drug resistance. To test for the 
reversible nature of the SOCE expression under normal 
salt (basal condition) treatment following high salt 
treatment (for 8 passages), we have cultured the MCF-
7s cells in regular basal conditions for 5 passages (these 
cells will be referred as MCF-7sr cells). As shown in 
Figure 3E–3G, reversing the salt treatment conditions to 
basal levels in MCF-7sr cells reversed the expression of 
Orai1, STIM1 and P-glycoprotein to basal levels. These 
data suggest that the high induced SOCE expression and 
P-glycoprotein mediated drug resistance is a reversible 
phenomenon.
Figure 2: (A) Western blot analysis to demonstrate the expression of Orai1 and STIM1 followinh high salt treatment (Δ0.05 M NaCl). 
(B, C) Inhibition of Orai1 (B) and STIM1 (C) following high salt+specific siRNA treatment. (D) Fluo-3 Ca2+ measurement indicates that 
STIM1 siRNA and Orai1 siRNA decrease store-operated Ca2+ influx in MCF-7 cells. (E, F) Inhibition of inflammatory cytokine TNF-α 
(E), and inflammatory chemokine CXCL12 (F) expression MCF-7 and MDA-MB-231 breast cancer cells in following siRNA based knock 
down of Orai1 and STIM1. Data were representative of five experiments and shown as mean ± SEM, p < 0.05.
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Enhanced tumorigenicity of high salt pre-treated 
breast cancer cells
To determine the effect of high salt passage on 
tumorigenicity of breast cancer cells we performed in 
vivo studies. Orthotopic tumors were induced following 
intramammary injection of 5 × 105 cancer cells (MCF-7 
or MCF-7s) in Nu/J mice. As shown in Figure 4A, tumor 
volume at the end of day 39 in mice injected with high 
salt passaged MCF-7s cells was 498 ± 41 mm3; while 
tumor volume in mice injected by MCF-7 cells on day 
39 was 271 ± 43 mm3 (p < 0.05). Further, mRNA based 
gene expression analyses (Figure 4B–4D) demonstrated 
an enhanced expression of SOCE regulatory molecules 
Orai1 and STIM1, and drug resistance protein P-gp. 
Using cell based phosphoproteomics approach and further 
functional analyses; we have previously demonstrated salt 
inducible kinase-3 (SIK3) mediates high salt mediated cell 
proliferation and inflammatory responses. In our current 
in vivo studies, we further confirm that in the orthotopic 
MCF-7s tumors there is 3.3 (p < 0.05) fold enhanced 
expression of SIK3 (Figure 4E) compared to orthotopic 
MCF-7 induced tumors. These data suggest that high 
salt pretreatment enhances the cell proliferation and 
tumorigenicity of breast cancer cells.
Decreased tumorigenicity following knock down 
of Orai1 in high salt pre-treated breast cancer 
cells
As SOCE mediated calcium influx regulator Orai1 
played a critical role in high salt mediated inflammatory 
response and paclitaxel resistance, we next tested the 
impact of Orai1 knock down on the in vivo tumorigenicity 
of breast cancer cells. Orthotopic tumors were induced with 
MCF-7s control shRNA treated (MCF-7s-Cntl-shRNA) or 
Orai1 shRNA treated (MCF-7s-Orai1-KO) in Nu/J mice. 
As shown in Figure 5A, tumor volume at the end of day 
39 in mice injected with high salt passaged MCF-7s cells 
was 483 ± 64 mm3; while tumor volume in mice injected 
by Orai1-KO-MCF-7s cells on day 39 was 316 ± 72 mm3 
(p < 0.05). Further, mRNA based gene expression analyses 
(Figure 5B–5D) demonstrated a diminished expression of 
SOCE regulatory molecules Orai1 and STIM1, and drug 
resistance protein P-gp. However, SIK3 expression (Figure 
5E) remained unchanged with or without Orai1 knock 
down in MCF-7s cell induced tumors. These data indicated 
to us that SIK3 is upstream to SOCE regulators in high salt 
mediated tumorigenicity of breast cancer cells.
Critical role of SIK3 in high salt mediated 
enhanced tumorigenicity
Previous phosphoproteomics based data from 
our laboratory demonstrated an enhanced expression 
and phosphorylation of SIK3 in breast cancer cells 
following high salt treatment. Further, we have shown 
that SIK3 mediates G0/G1-cell cycle release leading 
to mitotic cell division and cell proliferation [6]. Our 
initial studies (Figures 4 and 5) have demonstrated an 
enhanced expression of SIK3 in high salt passaged MCF-
7s breast cancer cells. Therefore, we tested if SIK3 plays 
a role in SOCE mediated calcium influx following high 
salt treatment. As shown in Figure 6A, 6B, thapsigargin 
emptied intracellular Ca2+ stores in the absence of 
extracellular Ca2+, followed by the Ca2+ influx measured 
by addition of 2 mM extracellular Ca2+ demonstrated that 
knock down of SIK3 reduced calcium influx and thus 
suggesting that SIK3 plays a direct role in calcium influx. 
To determine the tumorigenicity, we injected shRNA 
mediated SIK3 knock out MCF-7s cells into Nu/J mice. 
As shown in Figure 6C, tumor volume at the end of day 
39 in mice injected with high salt passaged MCF-7s cells 
was 478 ± 79 mm3; while tumor volume in mice injected 
by SIK3-KO-MCF-7s cells on day 39 was 164 ± 57 
mm3 (p < 0.05). Further, mRNA based gene expression 
analyses (Figure 6D–6G) demonstrated a diminished 
expression of SIK3, SOCE regulatory molecules Orai1 
and STIM1, and drug resistance protein P-gp. These data 
clearly demonstrated to us that SIK3 is upstream signaling 
molecule to SOCE regulated calcium influx in high salt 
mediated tumorigenicity of breast cancer cells.
Specific anti-tumor effect of prostratin on high 
salt treated breast cancer cells 
We have recently demonstrated that prostratin, 
a small molecule identified in the tea from the bark of 
Somoan tree and extensively studied in HIV research, 
induced a cytotoxic effect specifically on high salt treated 
breast cancer cells potentially through SIK3 inhibition 
[19]. We tested if prostratin could inhibit calcium influx 
and the tumorigenicity of high salt passaged breast cancer 
cells. We have orally administered prostratin (100 μM) 
Figure 3: (A) Impact of high salt treatment on paclitaxel resistance. MCF-7 cells were cultured under basal conditions; MCF-7s cells 
were passaged eight times in high salt added cell culture media (Δ0.05 M NaCl). (B) Pharmacokinetic parameters of paclitaxel cytotoxicity 
following various treatment conditions. (C) Western blot analysis of P-glycoprotein expression following high salt treatment. MCF-7s, 
represent MCF-7 cells were passaged eight times in high salt added cell culture media (Δ0.05 M NaCl); 231s, represents MDA-MB-231 
cells passaged eight times in high salt added cell culture media (Δ0.05 M NaCl). (D) Impact of high salt treatment on intracellular 
Rhodamine-123 accumulation. Rhodamine 123 is pumped out of the cell during enhanced expression of P-glycoprotein. (E–G) The high 
salt treated cells (for 8 passages) were latter cultured in normal salt containing basal media for 5 passages (referred to as MCF-sr) and then 
tested for the expression of Orai1 (E), STIM1 (F) and P-glycoprotein (G). Data were representative of five experiments and shown as mean 
± SEM, p < 0.05.
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into Nu/J mice two weeks prior to injection of MCF-7s 
cells. As shown in Figure 7A and 7B, thapsigargin emptied 
intracellular Ca2+ stores in the absence of extracellular Ca2+, 
followed by the Ca2+ influx measured by addition of 2 mM 
extracellular Ca2+ along with 8 μM prostratin demonstrated 
reduced calcium influx compared with vehicle control 
treated MCF-7 cells. Further, we orally administered 
prostratin (100 μM) into Nu/J mice two weeks prior to 
injection of MCF-7s cells. As shown in Figure 7C, tumor 
volume at the end of day 39 in mice injected with vehicle 
treated high salt passaged MCF-7s cells was 491 ± 68 mm3; 
while tumor volume in mice injected by prostratin treated 
MCF-7s cells on day 39 was 245 ± 62 mm3 (p < 0.05). 
However, prostratin treatment in MCF-7 cells cultured 
under basal conditions did not demonstrate inhibition of 
tumorigenicity. Further, mRNA based gene expression 
analyses (Figure 7D–7G) demonstrated a diminished 
expression of SIK3, SOCE regulatory molecules Orai1 
and STIM1, and drug resistance protein P-gp. These data 
clearly demonstrated to us that prostratin exerts anti-tumor 
effect specifically on high salt pre-treated breast cancer 
cells possibly through inhibition of SIK3-SOCE signaling.
DISCUSSION
Ca2+ is one of the most important signaling 
molecules known to regulate multiple cellular processes 
including, transcription, secretion of intracellular 
cytokines and cell division [20]. Multiple lines of 
evidence strongly suggests that cancer cells upregulate 
intracellular Ca2+-related signaling along with constant 
alterations in the expression and/or activity of calcium 
channels and pumps on the cell membrane [21]. Cancer 
cells are considered to undergo these changes to sustain 
their own cellular proliferation and to avoid cell death 
events. Human sodium-MRI evidence demonstrated 
high sodium concentration in breast tumors [7], although 
the functional significance of this high sodium in 
tumor microenvironment is unknown. While the exact 
reasons for the high sodium concentration in tumor 
microenvironment are unknown, previous studies from our 
laboratory demonstrated that high salt treatment on breast 
cancer cells induced inflammatory and cell proliferative 
responses [5, 22, 23]. As calcium signaling is one of the 
key mediators of these cellular responses too, in this study 
we evaluated if high salt treatment induces Ca2+ influx. 
Our current studies demonstrated that high salt treatment 
in breast cancer cells induced inflammatory response 
through SOCE regulated Ca2+ influx mediated signaling. 
Our current cancer cellular evidence corroborates well 
with evidence by Yang et al., wherein, they have shown 
SOCE mediated signaling is critical for the invasiveness 
of breast cancer cells [24]. These data suggest that SOCE 
regulated Ca2+ influx mediated signaling plays a critical 
role in multiple pro-cancer cellular processes. Further 
studies are needed to confirm our observations utilizing 
Figure 4: Tumorigenicity of MCF-7 and MCF-7s breast cancer cells. (A) Temporal changes in the tumor volume following 
injection of 5 × 105 MCF-7 and MCF-7s cells into Nu/J (n = 6) mice. (B–E) The mRNA expression of Orai (B), STIM1 (C), P-glycoprotein 
(D), and SIK3 (E). Data were represented as mean ± SEM, n = 6 per cohort, p < 0.05.
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Figure 5: Tumorigenicity of high salt passaged breast cancer cells following shRNA knock down of Orai1 expression. 
(A) Temporal changes in the tumor volume following injection of 5 × 105 MCF-7 and MCF-7s cells into Nu/J (n = 6) mice. (B–E) The 
mRNA expression of Orai (B), STIM1 (C), P-glycoprotein (D) and SIK3 (E). Data were represented as mean ± SEM, n = 6 per cohort, 
p < 0.05.
Figure 6: (A) Fluo-3 Ca2+ measurement following siRNA knock down of SIK3 in MCF-7 cells. Westernblot analysis to demonstrate 
SIK3-siRNA knock down efficiency (H/s refers to high salt). (B) Impact of high salt treatment plus SIK3 knock down on intracellular 
Rhodamine-123 accumulation. (C) Tumorigenicity of high salt passaged breast cancer cells following shRNA knock down of SIK3 
expression. Temporal changes in the tumor volume following injection of 5 x 105 MCF-7 and MCF-7s cells into Nu/J (n = 6) mice. (D–G) 
The mRNA expression of Orai (D), STIM1 (E), P-glycoprotein (F) and SIK3 (G). Data were represented as mean ± SEM, n = 6 per cohort, 
p < 0.05.
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complete and conditional STIM1 and Orai1 knock out 
murine models. Also in it important to note that STIM1 
expression is influenced by temperature changes [25]. As 
inflammatory responses could induced local changes in 
the basal cellular temperatures, future studies are needed 
to study the impact of temperature on high salt induced 
SOCE expression. 
The overexpression of P-gp is one of the well-
known mechanisms by which breast cancers cells 
develop chemo-drug resistance [26]. In this study we 
investigated if high salt treatment induces expression of 
P-gp. We demonstrated that high salt induces paclitaxel 
resistance through SOCE regulated Ca2+ influx mediated 
signaling P-gp overexpression (Figure 8). Xie et al. have 
demonstrated that the expression of P-gp is also regulated 
by post-translational events, such as post-transcriptional 
glycosylation and membrane localization of P-gp [27]. 
Therefore, using rhodamine 123 assay we demonstrated 
that high salt induces stable localization of P-gp and thus 
possibly inhibiting paclitaxel mediated cytotoxicity on 
breast cancer cells. Complex functional mechanisms have 
been noted between the P-gp-mediated drug resistance 
and intracellular calcium homeostasis. Our current studies 
support the previous studies by Gibalova et al., where 
in they demonstrated that the Ca2+ influx was enhanced 
in cells with P-gp overexpression [28]. Further, a higher 
intracellular calcium concentration was noted in P-gp-
positive MCF-7 breast cancer cells as compared with 
its P-gp-negative MCF-7 cells [29]. Taken together, our 
current studies support a notion that high salt in the tumor 
microenvironment induce P-gp mediated drug resistance 
in breast cancer. 
SOCE regulate Ca2+ signaling has been implicated 
in various oncological processes including dysplasia, 
metastasis and angiogenesis [30]. SOCE is also known 
to induce extracellular secretion of vascular endothelial 
growth factor (VEGF), which increase tumor vascularity 
and tumor progression [31]. While SOCE in cancer cells 
is known to promote tumorigenicity, SOCE mediated 
Ca2+ signaling in known to activate cytotoxic CD8+T-
lyphocytes which induce anti-tumor effect [32]. Therefore, 
to specifically study the tumorigenic role of high salt 
induced SOCE in cancer cells we performed in vivo studies 
in the immunodeficient Nu/J mice. Our in vivo studies 
demonstrated that high salt pre-treated breast cancer 
cells display enhanced tumorigenicity compared with 
breast cancer cells passaged under basal media culture 
conditions. These data point out an important functional 
role of high salt towards breast tumor progression. 
Previous phosphoproteomics based studies 
from our laboratory demonstrated overexpression and 
phosphorylation of SIK3 following high salt treatment 
[6]. Further we reported that prostratin, a small molecule 
inhibitor, known to inhibit HIV reactivation in CD4+T-
lymphocytes, plays an important role in SIK3inhibition 
[19]. In our current study, we demonstrated that prostratin 
was specifically effective against high salt pre-treated breast 
cancer cells. This supports our previous in vitro studies 
wherein we demonstrated that prostratin was upto 5 fold 
more cytotoxic on high salt pre-treated breast cancer cells. 
In conclusion, we determined the molecular 
functionality of high salt on breast cancer cells towards 
induction of their tumorigenicity and drug resistance 
through SOCE regulated Ca2+ influx. The Orai1 and 
STIM1 inhibition could offer novel anti-cancer therapeutic 
Figure 7: (A) Fluo-3 Ca2+ measurement following Prostratin (8 µM) plus high salt treatment on MCF-7 cells. (B) Impact of high salt plus 
Prostratin (8 µM) treatment on intracellular Rhodamine-123 accumulation. (C) Tumorigenicity of high salt passaged breast cancer cells 
following oral administration of prostratin (100 µM). Temporal changes in the tumor volume following injection of 5 × 105 MCF-7 and 
MCF-7s cells into Nu/J (n = 6) mice. (D–G) The mRNA expression of Orai (D), STIM1 (E), P-glycoprotein (F) and SIK3 (G). Data were 
represented as mean ± SEM, n = 6 per cohort, p < 0.05.
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strategies. Further, our current evidence to support the 
anti-tumor effect of prostratin could evoke further research 
to study the potential novel application of this small 
molecule inhibitor as an independent or add-on drug to 
the current breast cancer treatment regimen. 
MATERIALS AND METHODS
Cell culture 
Breast cancer cells (MCF7 and MDA-MB-231) 
were utilized and obtained from the American Type 
Culture Collection (ATCC, Manassas, VA) and cultured 
in cell basal essential media (RPMI1640 media, Thermo 
Fisher Scientific, Waltham, MA) along with the media 
supplements such as fetal bovine serum, penicillin/
streptomycin, fungizone, HEPES and glutamine, as 
recommended by the manufacturer and as previously 
described [5, 33]. Cell lines were frozen in liquid vapor 
nitrogen at –130° C until use. Upon thawing, cells were 
maintained in 5% CO2 incubator in sterile essential 
media at 37° C. For salt treatment conditions, cell culture 
media was supplemented with 0.05 M NaCl (Sigma 
Aldrich, St Louis, MO). We have previously performed 
a dose-response for salt (0–0.1 M NaCl) and found-out 
that 0.05 M NaCl provided highest cell proliferation 
[5, 23]. All chemicals unless mentioned were obtained 
either from Sigma Aldrich (St Louis, MO) or Thermo 
Fisher Scientific (Waltham, MA). The siRNA constructs 
against human STIM1 and Orai1 were generated using 
the pSUPER.retro vector according to the manufacturer’s 
instructions (OligoEngine). The sequences used were 
5′-GGCTCTGGATACAGTGCTC-3′ for STIM1 
and 5′-CGTGCACAATCTCAACTCG-3′ for Orai1; 
5′-GTGCAGAGTGTTGGAGTCC -3′ for SIK3. siRNA-
transfected cells were selected using puromycin. For 
murine injections cells were transfected by the following 
shRNA: Orai shRNA (sc-76001-SH, Santa Cruz Biotech), 
and SIK3 shRNA (sc-97056-SH, Santa Cruz Biotech). 
Prostratin (Sigma Aldrich) treatment on cell lines was 
performed to determine the effect of the drug on calcium 
influx. All other chemical unless mentioned were obtained 
from Sigma Aldrich and Invitrogen. 
Animal studies
All animal work was performed in accordance with 
protocols approved by the Institutional Animal Care and 
Use Committee of Vanderbilt University Medical Center. 
Immunodeficient Nu/J mice (Jackson labs) mice were used 
for studying the tumorigenicity. The MCF-7 (and high salt 
passaged MCF-7s) cells were trypsinized and washed with 
PBS before intramammary injection (5 × 105 cells/mice) 
into mice. The tumor volume was calculated using the 
Figure 8: Schematic on the mechanism by which high salt induces calcium influx and P-glycoprotein mediated drug 
resistance.
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formula V = (W^(2) × L)/2 from caliper measurements, 
where V is tumor volume, W is tumor width and L is 
tumor length [34].
Westernblot 
Total proteins were extracted from cells with 
lysis buffer for Western blot analysis as previously 
described [35, 36]. Total proteins were separated on a 
4–12% sodium dodecyl sulfate-polyacrylamide gradient 
gel and transferred onto a nitrocellulose membrane. 
The membranes were blocked overnight at 4° C in Tris-
buffered saline with 0.05% Tween 20 (5% nonfat milk in 
10 mM Tris-HCl-100 mM NaCl-0. 1% Tween 20, pH 7.4). 
The membranes were incubated first with Abs specific for 
total and phosphorylated forms at room temperature with 
primary Abs diluted 1 in 1,000 in blocking buffer for 2 
hrs, and then with a horseradish peroxide-conjugated 
secondary IgG mAb diluted 1 in 5,000 for 1hr. All primary 
and secondary Abs were obtained from Santa Cruz Biotech 
(Dallas, TX). The following specific primary antibodies to 
Orai1 (sc-377281), STIM1 (sc-66173), P-gp (sc-55510), 
GADPH (sc-47724) and Actin (sc-8432) were used. The 
membrane was developed using the chemiluminescence 
kit (Millipore) and analyzed on using Bio-Rad Universal 
Hood II (Hercules, CA). Morphometric analysis was done 
using the software provided by the company. 
Quantitative real time polymerase chain reaction 
(qRT-PCR) 
Expression profiles of genes at mRNA level in the 
breast cancer cell lines were analyzed using the TaqMan 
FAM-labeled RT-PCR primers for SIK3 (Hs00228549_
m1), STIM1 (Hs00963377_m1), Orai1(Hs00385627_
m1), P-gp (Hs00184500_m1), GADPH (Hs402869), and 
Actin (Hs4333762T), obtained from Applied Biosystems/
Thermo Fisher Scientific (Grand Island, NY) as per the 
manufacturer’s recommendation. Briefly, total RNA 
was extracted from 106 cells using TRIzol reagent 
(Sigma–Aldrich) and analyzed as mentioned previously 
[22, 37, 38]. RNA samples were quantified by absorbance 
at 260 nm. The RNA was reverse-transcribed and RT-
PCR (real time PCR) was performed in a final reaction 
volume of 20 μL using BioRad CFX96 (Hercules, CA). 
Each sample was analyzed in triplicate. Cycling conditions 
consisted of an initial denaturation of 95° C for 15min, 
followed by 40 cycles of 72° C for 30 s, followed by 61° C 
for 1 min.
Calcium influx assay
Calcium assays were performed using Fluo-3 
(Sigma Aldrich) solubilized to 10 mg/ml with dimethyl 
sulfoxide. Cells were loaded with 4 μg/ml Fluo-3 for 30 
minutes at 37° C. Cells were washed three times in HEPES 
buffered saline solution (HBSS with 1 mM CaCl2, 0.5 mM 
MgCl2, 0.1% BSA, 10 mM HEPES) and resuspended to 
1 × 106 cells/ml in HEPES buffered saline solution. For 
measurement of store-operated Ca2+ influx, 3 mM EGTA 
and 2 mM thapsigargin were added to deplete internal 
calcium stores. Ca2+ influx was induced by subsequent 
addition of 2 mM Ca2+ (free) after store depletion [24, 39]. 
The emission wavelength set at (λem) 485 nm and capture 
excitation wavelength set (λex) at 520 nm. The relative 
fluorescence detection was performed using FilterMax F5 
spectrophotometer (Molecular Devices, Sunnyvale, CA) 
and data obtained using instrument software. 
Rhodamine 123 assay
P-gp activity was determined by measuring 
intracellular accumulation of rhodamine 123 [40]. The 
breast cancer cells under various treatment conditions. 
Briefly, cells were incubated at 37° C with 5.25 μM 
rhodamine 123 for 60 min. After washing in HBSS, cells 
were lysed in distilled water, and intracellular levels 
of rhodamine 123 were quantified by FilterMax F5 
spectrophotometer (Molecular Devices, Sunnyvale, CA) 
and data obtained using instrument software. The emission 
wavelength set at (λem) 485 nm and capture excitation 
wavelength set (λex) at 535 nm. Data were expressed as 
percentage (%) of rhodamine 123 accumulation in control 
cells arbitrarily set at 100%.
Statistical Analysis
Data are expressed as mean ± SEM from five 
independent studies. Statistical differences between means 
were analyzed using a paired or unpaired Student’s t test. 
A value of p less than 0.05 was considered significant. All 
data analysis was obtained using Origin 6 software (Origin 
Labs, Northampton, MA) or SPSS software, version 21 
(IBM corporation, Armonk, NY).
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